Heimdal Entofarm ApS: Financial statements 2019
CVR: 37590339
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Heimdal Entofarm ApS (CVR 37590339) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -412,148 and a net result of DKK -546,476. Equity in the 2019 report amounted to DKK -765,425. The company had 1 employee in the financial year.
- Gross Profit
- DKK -412,148
- Profit/Loss
- DKK -546,476
- Equity
- DKK -765,425
- Total Assets
- DKK 797,829
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Heimdal Entofarm ApS has published its interim report for the period October 1, 2017 – December 31, 2018.
As of February 20, 2019, Søren Pasgaard has joined the board of directors of Heimdal Entofarm ApS.
As of February 20, 2019, Jakob Thrane Mainz has left the board of directors of Heimdal Entofarm ApS.
As of February 20, 2019, Mads Friche has left the board of directors of Heimdal Entofarm ApS.
As of February 6, 2019, Dorte Svenstrup is registered as chairman of Heimdal Entofarm ApS.
As of February 6, 2019, Ove Rønne has stepped down as chairman of Heimdal Entofarm ApS.
As of February 5, 2019, Dorte Svenstrup has left the board of directors of Heimdal Entofarm ApS.
About Heimdal Entofarm ApS
Heimdal Entofarm ApS was a Danish company of the type Anpartsselskab based in Tarm, founded in 2016. The company has been dissolved on 6 May 2025. The company was registered under the industry Avl af andre dyr. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK -148,599 and a net result of DKK -311,731 compared with DKK 4,067 the year before. Equity in the 2024 report amounted to DKK -1,986,612.